Jennifer Walsh, a public affairs director, was quoted in a Law360 article, “Health Care Policy to Watch in 2018,” about the political implications of health care reform and other health care policies in the new year.
Walsh told Law360 that she didn’t expect the Centers for Medicare & Medicaid Services to take any actions to encourage ACA signups, but believes the Republicans will pursue some of the same goals of the ACA repeal such as phasing out the law’s Medicaid expansion and block-granting Medicaid funds. “They’re going to try to move on to other, broader, Medicare and Medicaid entitlement reform, and probably wrap a lot of what they tried to do with Medicaid in repeal-replace into that discussion,” Walsh said.
She noted that is a a risky political move, especially in an election year, and especially when the stated purpose would be financing lower taxes for corporations and the wealthy. “It’s crazy,” Walsh said, “because the Democrats would love nothing more than for them to try to go after not just Medicaid but Medicare.”
Walsh told Law360 that she didn’t expect the Centers for Medicare & Medicaid Services to take any actions to encourage ACA signups, but believes the Republicans will pursue some of the same goals of the ACA repeal such as phasing out the law’s Medicaid expansion and block-granting Medicaid funds. “They’re going to try to move on to other, broader, Medicare and Medicaid entitlement reform, and probably wrap a lot of what they tried to do with Medicaid in repeal-replace into that discussion,” Walsh said.
She noted that is a a risky political move, especially in an election year, and especially when the stated purpose would be financing lower taxes for corporations and the wealthy. “It’s crazy,” Walsh said, “because the Democrats would love nothing more than for them to try to go after not just Medicaid but Medicare.”
People
Related News
January 15, 2026
In the News
Kyle Faget Assesses Regulatory Shifts Impacting Medtech
Foley & Lardner LLP partner Kyle Faget is featured in four Medtech Insight articles evaluating the medtech industry’s major developments in 2025 and examining 2026 regulatory challenges.
January 14, 2026
In the News
James Lundy on Stakes for Securities Industry as Disgorgement Case Heads to SCOTUS
Foley & Lardner LLP partner James Lundy addressed the impact a ruling from the U.S. Supreme Court would have on the securities industry in the Law360, “SEC To Lean On Congress As Defense In High Court Case.”
January 14, 2026
In the News
Natasha Allen on Companies Navigating AI Regulations – 'The issue right now is timing'
Foley & Lardner LLP partner Natasha Allen shared insight on how companies are navigating AI regulations in the Silicon Valley Business Journal article, “Silicon Valley companies navigate AI adoption as state and federal rules remain uncertain.”